Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
Comment by Macpooron Nov 14, 2024 6:20pm

RE:RE:RE:RE:RE:RE:Why grumble .... LABS is improving ....

The reason , I sleep like a baby at night is that LABS has no meaningful debts. A company without Zero debts survive . I feel that good days ahead , only we need to stay focused. I have invested ...more  
Comment by QContinuum1on Nov 14, 2024 4:09pm

RE:RE:RE:RE:RE:RE:Why grumble .... LABS is improving ....

Well how's that for a hi how are ya? So you're looking at nine months ending, I see.  I was looking at same Q. And I am plenty smart enough to understand that some things are out their ...more  
Comment by CADInvestor12on Nov 14, 2024 3:51pm

RE:RE:RE:RE:RE:Why grumble .... LABS is improving ....

LOL .. it amazes me how you can be sensible in one post and an utter moron in another, case and point... Not sure who makes me laugh more, you or Lemoyne.. Australia: 9-month Rev 2023 - $4.276M / 9 ...more  
Comment by QContinuum1on Nov 14, 2024 2:48pm

RE:RE:RE:RE:Why grumble .... LABS is improving ....

Australia was flat YoY and Canada was essentially the same.  Personally I don't see $200k increases on $2.5m as material increases, when all the guidance we have ever been given is just wait ...more  
Comment by lscfaon Nov 14, 2024 2:23pm

RE:Q3 - Germany WTF

Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License November 14, 2024 07:00 ET   https://www ...more  
Comment by CADInvestor12on Nov 14, 2024 2:05pm

RE:RE:RE:Why grumble .... LABS is improving ....

I don't disagree that Q3 was disappointing but you are completely wrong with your analysis of the financials ..  Australia is up 11% QoQ - All of Canada up 6.5% QoQ .. Germany is where it all ...more  
Comment by Starkickeron Nov 14, 2024 1:45pm

RE:RE:RE:Why grumble .... LABS is improving ....

All of that is true QC. If they are one of the few, if not the only ones, able to navigate highly regulated markets as they claim, then why such pitiful revenue? Somebody needs to explain that. Also ...more  
Comment by QContinuum1on Nov 14, 2024 1:09pm

RE:RE:Why grumble .... LABS is improving ....

Topline off from Q2, drob off a cliff, Australia flat, Canada cratered, Germany grew (if you can call it that) in a market that is apparently to be 400 million euros (med only) in 2024 with a massive ...more  
Comment by alleyesonmeon Nov 14, 2024 11:36am

RE:Why grumble .... LABS is improving ....

9 months ending sept 30th, revenue is up 25% as compared to the same period last year, German flower sales, measly, however up to 400k from 124k, it appears dronabinol dropped off a cliff this Q ...more  
Comment by QContinuum1on Nov 14, 2024 11:23am

RE:Why grumble .... LABS is improving ....

I grumble because they're not. 
Post by proneon Nov 14, 2024 10:33am

Why grumble .... LABS is improving ....

--->Adjusted EBITDA(1): Negative $743K in the three months ended September 30, 2024 ("Q3 2024"), significantly improved from negative $2.4M during the same period in 2023 ("Q3 2023 ...more  
Post by Starkickeron Nov 14, 2024 10:21am

Q3 presentation

Just read through the presentation... nothing new for anybody that's been paying attention. The $13M in cash concerns me considering there was $16M at end of Q2, (but understandable with $2.2 debt ...more  
Comment by CADInvestor12on Nov 14, 2024 9:44am

RE:RE:Q3 - Germany WTF

If there was a meaningful update on pharma initiatives, then I could've lived with this ... but again nothing, and the first real let down from Pidduck.  Looks like they sold under $100 of ...more  
Comment by okgonowon Nov 14, 2024 9:41am

RE:RE:RE:RE:Q3 - Germany WTF

ignore all that i said those are the wrong numbers
Comment by okgonowon Nov 14, 2024 9:40am

RE:RE:RE:Q3 - Germany WTF

i dont think its as bad a you think it is actually have a closer look at the tables they put out there are some omne time codts they put on the spreadsheet  im no accountant   ...more